【Introduction】 Rheumatoid arthritis and other autoimmune diseases and orthopedic diseases.
【Advantage】 Class 1 innovative drug independently developed by China in the 1990s, holding the national invention patent (ZL94113006.1) and the certificate of “National Key New Product”.
|